Seeing the Whole Picture with Advanced OCT-A Technology and Ultra Widefield Fundus Imaging

How can combining advanced OCT and ultra-widefield retinal imaging help you detect pathology earlier and improve patient outcomes?

Mile Brujic, OD, FAAO shares how he integrates the Optovue Solix OCT and the iCare EIDON Widefield Fundus Imaging into his daily clinical workflow to enhance diagnostic confidence and elevate patient care.

During this webinar, Dr. Brujic will review real-world patient cases that demonstrate the value of using these complementary technologies together to identify retinal pathology earlier, gain a more complete clinical picture, and support better-informed treatment decisions. He'll also discuss how Solix's single SOLO scan captures structural OCT, OCT-A, and FDA-cleared OCT/OCT-A metrics in one acquisition, providing quantitative vascular analysis while improving workflow efficiency.

You'll learn how to:

• Combine OCT and up to 200° ultra-widefield fundus imaging for a more comprehensive retinal evaluation.
• Detect pathology earlier through complementary imaging technologies.
• Understand how FDA-cleared OCT-A metrics can support clinical decision-making.
• Apply multimodal imaging insights using real-world patient cases.
• Improve workflow efficiency with an integrated retinal imaging approach.
  

About the Speaker

Mile Brujic, OD, FAAO is a 2002 graduate of the New England College of Optometry. He is a partner of Premier Vision Group, a successful four location optometric practice in Northwest Ohio. He practices full scope optometry with an emphasis on ocular disease management of the anterior segment and specialty contact lenses. He is active at all levels of organized optometry. Dr. Brujic is on the editorial board for several optometric publications. He has published over 500 articles and has given over 2,400 lectures, both nationally and internationally on contemporary topics in eye care. 

*This webinar was originally broadcast on September 8, 2026 with ODwire.org.

**The views and experiences expressed are those of the individual user. They may involve off-label use of the medical device, which is not endorsed or approved by the manufacturer. Not all products, accessories, services, or offers are approved in every market.